TD Cowen Sticks to Their Buy Rating for Rapport Therapeutics, Inc. (RAPP)
TipRanksAug 9 02:28
Rapport Therapeutics Analyst Ratings
BenzingaJul 2 17:55
Buy Rating for Rapport Therapeutics: Disruptive CNS Treatments and Promising Drug Efficacy
TipRanksJul 2 17:03
No Data